
If it feels like you’re hearing the word psilocybin more than CBD lately, you’re not imagining it. We’re in the middle of what many people are calling the “Shroom Boom.” Not long ago, the idea of legal psychedelics sounded like something far outside the mainstream. Now, it’s starting to look a lot like the early days of legal cannabis—more support, more research, and a big change in how people think about these substances.
Psychedelics are also getting a new image. Back in the 1960s, they were tied to figures like Timothy Leary and a “drop out” culture. Today, they’re being talked about in a very different way. In places like Silicon Valley, some people use small doses to focus better. At the same time, doctors and researchers are studying them to help people with PTSD, depression, and addiction—especially veterans.
Laws are changing too. Oregon was the first to allow adults to use psilocybin in licensed centers with trained guides. Colorado followed by allowing personal use and working on its own system for safe, guided experiences.
Other places are moving more slowly but still making progress. Alaska is studying how to regulate psychedelic treatments. California has started a program to research how these substances can help veterans and first responders. Some cities, like Cambridge, Somerville, and Seattle, have made enforcement of laws against these plants a low priority.
More states are getting involved. Arizona is spending millions to study a substance called ibogaine for addiction and PTSD. Connecticut is thinking about funding therapy programs that use psychedelics. Illinois and Minnesota are also working on new laws.
Then, on April 18, 2026, Donald Trump signed an executive order that gave the movement a big push. The order tells the FDA to speed up reviews of psychedelic treatments. It also sets aside $50 million for research and highlights ibogaine as a possible treatment for opioid addiction and PTSD. It even opens the door to changing how some of these substances are classified under federal law if they pass major clinical trials.
All of this is happening now because people are starting to see real benefits. Just like cannabis went from being seen as a “drug” to being used for health and wellness, psychedelics are being looked at in a new way. Many believe they can help the brain heal and grow.
At this point, it’s not really a question of if psychedelics will become more accepted. The real question is how fast it will happen—and what it will look like when it does.
Dabbin-Dad Newsroom

